RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE-OMI)today reported financial results for the third quarter ended September 30, 2019, as summarized in the table below.
“I am excited to announce that we had another quarter with significant sequential improvement. Our third quarter results show back-to-back quarters of sequential growth in operating income and EPS, expansion of quarterly operating cash flow, additional reduction in working capital and an increased pace of debt pay down. This is a result of our teammates actively embracing our focus around serving our customers and driving productivity,” said Edward A. Pesicka, President & Chief Executive Officer of Owens & Minor.
“Additionally, we have improved our service metrics to levels that have not been achieved in years. The strong performance and consistency of our service gives us confidence that many of the past service issues have been resolved, however we will continue to drive additional initiatives to further improve and provide innovative services. We continue to focus on productivity and efficiency initiatives to drive operating improvements in our core businesses: distribution channel, product manufacturing, home healthcare, and acute care services. While we are ahead of the long-term recovery plan I envisioned when I joined in March, we recognize that there is still a significant amount of work ahead. We will not take our customers for granted and will continue to provide a high level of customer focus while maintaining industry- leading integrity.”
2019 Results
- Foreign exchange negatively impacted net income per share and adjusted net income per share by $0.02 for both the quarter and year-to-date. On a constant currency basis, adjusted net income per share was $0.22 for the third quarter and $0.34 on a year-to-date basis.
- Compared to prior year, quarterly revenues declined 2.7%, and year-to-date revenues grew 0.7% (2.4% decline and 1.0% increase, respectively, on a constant currency basis).
- The changes in quarterly and year-to-date revenues were driven by increased sales from Global Products and certain business lines within Global Solutions, offset by lower distribution sales.
- Quarterly and year-to-date operating results reflect margin expansion from improved sales mix offset by expenses to support business growth and new customer solutions as well as delayed revenue associated with Fusion5.
- Interest expense increased $2.1 million for the quarter and $28.1 million year-to-date compared to prior year.
Highlights
- On a sequential basis, during the third quarter of 2019 the Company achieved operating income growth of 57% and adjusted operating income growth of 15%.
- On a sequential basis, net income and adjusted net income per share increased $0.20 and $0.10, respectively.
- The Company generated $110 million of operating cash flow in the third quarter; total of $200 million in operating cash flow generated in the second and third quarters.
- Reduced debt by $72 million in the third quarter; $130 million total reduction in debt over the second and third quarters.
- On a sequential basis, interest expense for the quarter decreased $1.7 million.
- Achieved historically strong service levels.
- Byram continues strong top-line and bottom-line performance.
- Successfully exited transition service agreements related to the Halyard S&IP acquisition.
- Mark Beck, former President and Chief Executive Officer of JELD-WEN Holding, Inc. and Robert Henkel, former President and Chief Executive Officer of Ascension Health, Inc. were elected to Board of Directors in the third quarter.
Financial Outlook
For 2019, the Company is adjusting its previously issued guidance range for the timing and amount of anticipated revenue from its early stage value-based care management business (Fusion5) as follows:
| Adjusted net income per share range, excluding foreign currency impact | ||||
| Narrowed guidance range | $0.60 | $0.65 | ||
| Impact of Fusion5 revenue amount and timing | (0.06 | ) | (0.06 | ) |
| $0.54 | $0.59 | |||
Excluding the impact of Fusion5 and foreign currency, the company now expects 2019 adjusted net income per share to be in a range of $0.60 to $0.65.
Although the company does provide guidance for adjusted net income per share (which is a non-GAAP financial measure), it is not able to forecast the most directly comparable measure calculated and presented in accordance with GAAP without unreasonable effort. Certain elements of the composition of the GAAP amount are not predictable, making it impracticable for the company to forecast. Such elements include, but are not limited to restructuring and acquisition charges. As a result, no GAAP guidance or reconciliation of the company’s adjusted net income per share guidance is provided. For the same reasons, the company is unable to assess the probable significance of the unavailable information, which could have a potentially significant impact on its future GAAP financial results. The outlook is based on certain assumptions that are subject to the risk factors discussed in the company’s filings with the Securities and Exchange Commission (“SEC”).
Dividend Information
The Board of Directors approved a fourth quarter dividend payment of $0.0025 per share, payable on December 31, 2019, to shareholders of record as of December 16, 2019.
About Owens & Minor
Owens & Minor, Inc. (NYSE: OMI) is a global healthcare solutions company with integrated technologies, products, and services aligned to deliver significant and sustained value for healthcare providers and manufacturers across the continuum of care. With 17,000 dedicated teammates serving healthcare industry customers in 90 countries, Owens & Minor helps to reduce total costs across the supply chain by optimizing episode and point-of-care performance, freeing up capital and clinical resources, and managing contracts to optimize financial performance. A FORTUNE 500 company, Owens & Minor was founded in 1882 in Richmond, Virginia, where it remains headquartered today. The company has distribution, production, customer service and sales facilities located across the Asia Pacific region, Europe, Latin America, and North America. For more information about Owens & Minor, visit owens-minor.com, follow @Owens_Minor on Twitter, and connect on LinkedIn at www.linkedin.com/company/owens-&-minor.

